Hyderabad: The phase-2 clinical trial of the indigenously developed Covaxin began on Tuesday in Nagpur.
Bharat Biotech, the Hyderabad-based firm behind it, is testing the vaccine at Nagpur’s Gillurkar Hospital. In the first phase, 55 volunteers had undergone the test.
None of the volunteers reported any complication after the first dose. The vaccine trial will continue with a gap of 28 days, 42 days, 104 days and 194 days. The blood samples will be checked for growth in antibodies after each dose.
New Delhi: Union Ministers Kiren Rijiju and Dharmendra Pradhan demanded an apology from Leader of…
Bhubaneswar: Union Home Minister Amit Shah is likely to undertake a two-day visit to Odisha…
Baripada: In a first in India, a dedicated company of armed police constabulary will be deployed…
Bhubaneswar: The 9th Edition of SAI Olympics at SAI International School has kicked off in…
New Delhi: Amid the controversy sparked over Union Home Minister Amit Shah's remarks on Dr…
Bhubaneswar: A central team has arrived in Bhubaneswar to finalise the modalities for integration of…
This website uses cookies.